vancomycin, although resistance to this agent has emerged. Alternative available treatments for MRSA include teicoplanin …

daily) and amikacin (15 mg/kg/day, in 3 separate doses) plus teicoplanin (6 mg/kg, in a single dose) or vancomycin (30 mg … teicoplanin- rather than the vancomycin-containing regimen. Conclusions: This retrospective cost analysis showed that despite the … higher acquisition cost of teicoplanin relative to vancomycin, the lower incidence of adverse effects associated with …